This site is intended for healthcare professionals
Drug news

Positive top-line results from MYRROR trial of Eylea (Regeneron/Bayer HealthCare) for Choroidal Neovascularization

Read time: 1 mins
Last updated:8th Jun 2013
Published:8th Jun 2013
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest